IMMUPARKNET 2024 Annual Meeting

IMMUPARKNET 2024 Annual Meeting

This year IMMUPARKNET COST Action Annual Conference will take place in the beatiful city of Belgrade, Republic of Serbia, at the Royal Inn Hotel, from 20th to 22nd of April 2024, hosted by Dr. Tamara Saksida – University of Belgrade – Institute for Biological Research “Siniša Stanković” – National Institute of the Republic of Serbia.

You can find below the final program of the event and the complete abstract book.

_ Program _

  • 09.30 Registration
  • 10.00 Welcome and Action Presentation by Action Chair: Prof. Cristoforo Comi
  • 10.15 – 10.55 Updates on Working Groups – Meeting and Brainstorming WG1
  • 10.55 – 11.30 Coffee Break
  • 11.30 – 13.00 Updates on Working Groups – Meeting and Brainstorming WG2
  • 13.00 – 14.00 Lunch Break
  • 14.00 – 15.15 Updates on Working Groups – Meeting and Brainstorming WG3
  • 15.15 -16.30 Updates on Working Groups – Meeting and Brainstorming WG4
  • 16.30 – 17.30 Coffee Break
  • 17.00 – 18.30 MC Meeting
  • 18.30 Social events

  • 08.30 Registration
  • 09.00 – 10.15 Updates on Working Groups – Meeting and Brainstorming WG5
  • 10.15 – 10.50 Coffee break (2 posters by Marija Jeremić & Elena Rita Simula)
  • 10.50 – 12.15 Oral Presentations. Chairs: Marina Romero Ramos & Đorđe Miljković
    • Laura Muñoz-Delgado. Peripheral immune profile and neutrophil-to-lymphocyte ratio in progressive supranuclear palsy (online)
    • Julia Greenland. The effect of azathioprine on peripheral and central inflammation in Parkinson’s disease: exploratory biomarker data from the AZA-PD clinical trial
    • Marta Camacho. Gut function, ghrelin and the immune system in early Parkinson’s Disease
    • Shubhra Acharya. Long non-coding RNAs as neuroprotective targets in Parkinson’s disease
    • Tommaso Schirinzi. Phosphoproteomic profiling of peripheral immune cells from patients with Parkinson’s disease
  • 12.15 – 13.15 Lunch break
  • 13.15 – 14.40 Oral presentations. Chairs: Cristoforo Comi & Özgür Öztop Çakmak
    • Augustas Pivoriūnas. A new model describing interactions of extracellular vesicles with human microglia
    • Frida Lind-Holm Mogensen.  PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation
    • Milorad Dragić. Sustained systemic antioxidative effects of intermittent theta burst stimulation beyond neurodegeneration: implications in therapy in 6-hydroxydopamine model of Parkinson’s disease
    • Nicoleta Moisoi. Mitochondrial proteostasis influences microglia activation in neurodegeneration
    • Frederico C. Pereira. The interplay between catecholamines and myeloid cells is changed in PD patients
  • 14.40 – 15.15 Coffee break (2 poster presentations by Anđela Stekić & Maria Georgoula)
  • 15.15 – 16.40 Oral presentations. Chairs: Franca Marino & Milorad Dragić
    • Monica Pinoli. Transcription factor mRNA levels in circulating CD4+ T cells predict phenoconversion in Idiopathic REM Sleep Behavior Disorder (online)
    • Alessia di Flora. Comparative analysis of T cell phenotype shifts in immunosenescence across young, healthy elderly, and frail subjects
    • Christiana C. Christodoulou. Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data
    • Christa Nöhammer. Microbiome research tools beyond 16S rRNA and shotgun sequencing
    • Diego Clemente. Myeloid-derived suppressor cells as biomarkers of disease severity in multiple sclerosis: relevance to Parkinson’s disease?

  • 09.30 Registration
  • 10.00 – 10.45 Oral presentations. Chairs: Ines Figueira & Tamara Saksida
    • Kari Espolin Fladmark. Glial DJ-1 neuroprotection in a zebrafish Parkinson´s disease model
    • Sanja Blagojević. The effects of prolonged exposure to dopaminergic neurotoxins on AMPK and mTORC2 signaling
    • Lucia Silvera-Carrasco. Understanding the physiological functions of Activity-Dependent Neuroprotective Protein (ADNP) in microglial responses: linking neurodegeneration and neuroinflammation
  • 10.45 – 11.20 Coffee break (2 poster presentations by Marija Adžić Bukvić & Rana Abu Manneh)
  • 11.20 – 11.50 Oral presentations. Chairs: Ines Figueira & Tamara Saksida
    • Augustas Pivoriūnas. Scaling up production of extracellular vesicles – next step towards clinical therapies against Parkinson’s disease
    • Jinte Middeldorp. Neuroinflammation and neurodegeneration in SARS-CoV-2 infected macaques: A link between COVID-19 and Parkinson’s disease?
  • 12.00 Conclusions and Goodbye

_ Abstract book _

Share this post


Latest Updates

The Art of Living

Short-term Scientific Missions (STSM) are institutional visits aimed at supporting individual mobility and fostering collaborations by allowing scientists to visit an institution and contribute to...

WG2 animal

We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction...


🎉 Exciting News from IMMUPARKNET COST Action 21117 Annual Meeting! 🎉 This year’s IMMUPARKNET COST Action Annual Conference took place in the beautiful city of...


Last week, from 5 to 9 March, the groundbreaking series of Alzheimer’s and Parkinson’s disease (AD/PD 2024) conferences took place in Lisbon, at Centro de...


IMMUPARKNET call for applications for  short-term scientific missions (STSMs), inclusiveness target countries (ITC) Conference Grants and Dissemination Grants is currently open! Further and detailed information...


🧠 Neuroscience Academy Denmark Lecture on Parkinson’s Disease 🧠 🗓 Date & Time: March 22, 2024, 1:00 pm (CET) 🌐 Location: Aarhus University, Building 1613,...